Literature DB >> 18439605

The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis.

Kazuhiro Noma1, Keiran S M Smalley, Mercedes Lioni, Yoshio Naomoto, Noriaki Tanaka, Wafik El-Deiry, Alastair J King, Hiroshi Nakagawa, Meenhard Herlyn.   

Abstract

BACKGROUND & AIMS: Esophageal squamous cell carcinoma (ESCC) is known to be a highly angiogenic tumor. Here, we investigated the role of the stromal fibroblasts in the ESCC-induced angiogenic response using a novel 3-dimensional model.
METHODS: A novel assay was developed where cocultures of ESCC and esophageal fibroblasts induced human microvascular endothelial cell (HMVEC) vascular network formation in a 3-dimensional collagen gel. Biochemical studies showed that the ESCC-induced activation of the fibroblasts was required to induce vascular network formation via a transforming growth factor (TGF)-beta and vascular endothelial growth factor (VEGF)-dependent pathway.
RESULTS: Conditioned media from a panel of 4 ESCC lines transdifferentiated normal esophageal fibroblasts into myofibroblasts via TGF-beta signaling. The presence of fibroblasts was essential for efficient HMVEC network formation, and the addition of ESCC cells to these cultures greatly enhanced the angiogenic process. The role of TGF-beta in this process was shown by the complete inhibition of network formation following TGF-beta inhibitor treatment. Finally, we showed that ESCC-derived TGF-beta regulates angiogenesis through the release of VEGF from the fibroblasts and that the VEGF release was blocked following TGF-beta inhibition.
CONCLUSIONS: This study shows the essential role of fibroblasts in the ESCC angiogenic-induced response and suggests that the pharmacologic targeting of the TGF-beta signaling axis could be of therapeutic benefit in this deadly disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18439605      PMCID: PMC2562524          DOI: 10.1053/j.gastro.2008.02.061

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  30 in total

1.  Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo.

Authors:  Claudia D Andl; Takaaki Mizushima; Hiroshi Nakagawa; Kenji Oyama; Hideki Harada; Katerina Chruma; Meenhard Herlyn; Anil K Rustgi
Journal:  J Biol Chem       Date:  2002-11-14       Impact factor: 5.157

Review 2.  Putting tumours in context.

Authors:  M J Bissell; D Radisky
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

3.  Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells.

Authors:  U Renner; P Lohrer; L Schaaf; M Feirer; K Schmitt; C Onofri; E Arzt; G K Stalla
Journal:  Endocrinology       Date:  2002-10       Impact factor: 4.736

Review 4.  Role of tissue stroma in cancer cell invasion.

Authors:  Olivier De Wever; Marc Mareel
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

5.  SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.

Authors:  Stacey DaCosta Byfield; Christopher Major; Nicholas J Laping; Anita B Roberts
Journal:  Mol Pharmacol       Date:  2004-03       Impact factor: 4.436

6.  Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac.

Authors:  Olivier De Wever; Quang-Dé Nguyen; Leen Van Hoorde; Marc Bracke; Erik Bruyneel; Christian Gespach; Marc Mareel
Journal:  FASEB J       Date:  2004-04-01       Impact factor: 5.191

7.  Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma.

Authors:  Yasuyuki Fukai; Minoru Fukuchi; Norihiro Masuda; Hidenobu Osawa; Hiroyuki Kato; Takashi Nakajima; Hiroyuki Kuwano
Journal:  Int J Cancer       Date:  2003-03-20       Impact factor: 7.396

8.  Fibroblast-dependent differentiation of human microvascular endothelial cells into capillary-like 3-dimensional networks.

Authors:  Omaida C Velazquez; Ruthanne Snyder; Zhao-Jun Liu; Ronald M Fairman; Meenhard Herlyn
Journal:  FASEB J       Date:  2002-06-07       Impact factor: 5.191

9.  Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels.

Authors:  K S M Smalley; R Contractor; N K Haass; J T Lee; K L Nathanson; C A Medina; K T Flaherty; M Herlyn
Journal:  Br J Cancer       Date:  2007-01-23       Impact factor: 7.640

10.  A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.

Authors:  S Tanaka; M Mori; K Mafune; S Ohno; K Sugimachi
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

View more
  55 in total

1.  Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion.

Authors:  Katharine D Grugan; Charles G Miller; Yao Yao; Carmen Z Michaylira; Shinya Ohashi; Andres J Klein-Szanto; J Alan Diehl; Meenhard Herlyn; May Han; Hiroshi Nakagawa; Anil K Rustgi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Fibroblasts contribute to melanoma tumor growth and drug resistance.

Authors:  Edward H Flach; Vito W Rebecca; Meenhard Herlyn; Keiran S M Smalley; Alexander R A Anderson
Journal:  Mol Pharm       Date:  2011-11-08       Impact factor: 4.939

3.  Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.

Authors:  Yasushi Kojima; Ahmet Acar; Elinor Ng Eaton; Kieran T Mellody; Christina Scheel; Ittai Ben-Porath; Tamer T Onder; Zhigang C Wang; Andrea L Richardson; Robert A Weinberg; Akira Orimo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

4.  Cancer-associated fibroblasts are associated with poor prognosis in esophageal squamous cell carcinoma after surgery.

Authors:  Yufeng Cheng; Kai Wang; Wei Ma; Xiaomei Zhang; Yipeng Song; Jianbo Wang; Nana Wang; Qingxu Song; Fangli Cao; Bingxu Tan; Jinming Yu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

5.  Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth.

Authors:  Johanna Soikkeli; Piotr Podlasz; Miao Yin; Pirjo Nummela; Tiina Jahkola; Susanna Virolainen; Leena Krogerus; Päivi Heikkilä; Karl von Smitten; Olli Saksela; Erkki Hölttä
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

6.  Precise and Arbitrary Deposition of Biomolecules onto Biomimetic Fibrous Matrices for Spatially Controlled Cell Distribution and Functions.

Authors:  Chao Jia; Bowen Luo; Haoyu Wang; Yongqian Bian; Xueyong Li; Shaohua Li; Hongjun Wang
Journal:  Adv Mater       Date:  2017-07-19       Impact factor: 30.849

7.  Expression of basic fibroblast growth factor, CD31, and α-smooth muscle actin and esophageal cancer recurrence after definitive chemoradiation.

Authors:  Yongshun Chen; Xiaohong Li; Haijun Yang; Yubing Xia; Leiming Guo; Xiaoyuan Wu; Chunyu He; You Lu
Journal:  Tumour Biol       Date:  2014-04-29

8.  Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters.

Authors:  Qi-Lian Liang; Bi-Rong Wang; Guo-Qiang Chen; Guo-Hong Li; Yan-Yun Xu
Journal:  Med Oncol       Date:  2009-11-12       Impact factor: 3.064

Review 9.  Targeting the tumour stroma to increase efficacy of chemo- and radiotherapy.

Authors:  G Chometon; V Jendrossek
Journal:  Clin Transl Oncol       Date:  2009-02       Impact factor: 3.405

Review 10.  Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression.

Authors:  Masayuki Shimoda; Kieran T Mellody; Akira Orimo
Journal:  Semin Cell Dev Biol       Date:  2009-10-24       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.